• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Venator Materials PLC (Amendment)

    1/10/23 8:07:36 AM ET
    $VNTR
    Major Chemicals
    Industrials
    Get the next $VNTR alert in real time by email
    SC 13D/A 1 e618188_sc13da-venator.htm AMENDMENT NO. 3 TO THE SCHEDULE 13D

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

    ______________

     

    SCHEDULE 13D

    (Rule 13d-101)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    RULE 13d-2(a)

     

    (Amendment No. 3)1

     

    Venator Materials PLC

    (Name of Issuer)

     

    Ordinary Shares, US$0.001 par value per share

    (Title of Class of Securities)

     

    G9329Z100

    (CUSIP Number)

     

    J&T MS 1 SICAV a.s.

    Sokolovská 700/113a, Prague 8

    Czech Republic

    +420 720 757 352

    c/o Martin Seyček

     

    ELIZABETH GONZALEZ-SUSSMAN, ESQ.

    OLSHAN FROME WOLOSKY LLP

    1325 Avenue of the Americas

    New York, New York 10019

    (212) 451-2300

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    January 10, 2023

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ☐.

     

    Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

    (Continued on following pages) 

     


    1      The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. G9329Z100

      1   NAME OF REPORTING PERSON  
             
           

    J&T MS 1 SICAV a.s. 

     
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
           

    AF, WC 

     
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
           

    Czech Republic 

     
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING        

    15,401,123 

     
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              15,401,123  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            15,401,123  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
           

    14.25% 

     
      14   TYPE OF REPORTING PERSON  
             
           

    OO 

     

      

    2

    CUSIP No. G9329Z100

      1   NAME OF REPORTING PERSON  
             
           

    AMISTA investiční společnost, a.s 

     
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
           

    AF, WC 

     
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
           

    Czech Republic 

     
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING        

    15,401,123 

     
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              15,401,123  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            15,401,123  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
           

    14.25% 

     
      14   TYPE OF REPORTING PERSON  
             
           

    OO 

     

      

    3

    CUSIP No. G9329Z100

     

    This Amendment No. 3 (this “Third Amendment”) to Schedule 13D amends and supplements the Schedule 13D filed on June 3, 2022 (the “Original Schedule”), Amendment No. 1 to the Original Schedule filed on September 19, 2022 (the “First Amendment”) and Amendment No. 2 to the Original Schedule filed on December 21, 2022 (the “Second Amendment”), by J&T MS 1 SICAV a.s., a société d’investissement à capital variable (investment company with variable capital) established in the Czech Republic (“J&T MS 1”), and AMISTA investiční společnost, a.s., a joint stock company established in the Czech Republic (“AMISTA”). AMISTA is the sole director of J&T MS 1. J&T MS 1 SICAV and AMISTA are sometimes referred to herein collectively as the “Reporting Persons.” This Third Amendment is being filed because the Reporting Persons issued a press release and open letter to the Board as further described in Item 4.

     

    Except as specifically amended by this Third Amendment, items in the Original Schedule, the First Amendment and the Second Amendment, as applicable, are unchanged. Capitalized terms used herein that are not defined have the meaning ascribed to them in the Original Schedule.

     

    Item 3.Source and Amount of Funds or Other Consideration.

     

    Item 3 of the Original Schedule is hereby amended and supplemented to include the following paragraphs to the end of the item, after the paragraphs added by the Second Amendment:

     

    The Ordinary Shares acquired by the Reporting Persons since the Second Amendment was filed were bought by J&T MS 1 SICAV using investment funds in open market purchases, and those purchases since the Second Amendment was filed are set forth in Appendix A.

     

    The aggregate purchase price of the 15,401,123 Ordinary Shares owned directly by J&T MS 1 SICAV is approximately $23,869,172, excluding brokerage commissions.

     

    Item 4.Purpose of Transaction.

     

    Item 4 of the Original Schedule is hereby amended and supplemented to include the following sentence to the end of the first paragraph of the item, after the sentence added by the Second Amendment:

     

    On January 10, 2023, the Reporting Persons issued a press release and sent a public letter to the Issuer’s Board of Directors (the “Board”) regarding its concerns with the Issuer’s financial and stock price underperformance, massive shareholder value destruction, lack of strategic direction, and apparent unwillingness to meaningfully engage with the Reporting Persons. The Reporting Persons also stressed that the incumbent Board appears to have squandered its credibility with investors and should not be trusted to chart the course forward for the Issuer without additional independent shareholder representation. A copy of the press release and letter is attached hereto as exhibit 99.1 and is incorporated herein by reference.

     

    Item 5. Interest in Securities of the Issuer.

     

    Items 5(a)-(c) of the Second Amendment is deleted in its entirety and replaced with the following:

     

    (a)       J&T MS 1 is the holder of 15,401,123 Ordinary Shares, or 14.25%, of the issued and outstanding Ordinary Shares.

     

    4

    CUSIP No. G9329Z100

     

    Each of the Reporting Persons, as a result of the relationships described in Item 2, may be deemed to directly or indirectly beneficially own the Ordinary Shares held by J&T MS 1. Each of the Reporting Persons disclaims beneficial ownership in all shares of Ordinary Shares reported herein, except to the extent of its respective pecuniary interest therein.

     

    The ownership percentages reported in this Schedule 13D are based on 108,049,979 shares of Ordinary Shares outstanding of the Issuer, as of November 30, 2022, as communicated to the Reporting Persons by the Issuer on or around that date.

     

    (b)       See rows 7-10 of each cover page for information regarding the power to vote or direct the vote and the power to dispose or direct the disposition of the shares by the Reporting Persons.

     

    (c)       Except as disclosed in this Schedule 13D, the Reporting Persons and, to the Reporting Persons’ knowledge, the Covered Persons have not effected any transactions in the Issuer’s Ordinary Shares since the filing of the Second Amendment.

     

    Item 7.Material to be Filed as Exhibits.

     

    Item 7 is hereby amended to add the following exhibit:

     

    99.1Press release and letter to the Board of Directors of the Issuer, dated January 10, 2023.

     

    5

    CUSIP No. G9329Z100

     

    SIGNATURES

     

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Dated: January 10, 2023

     

      J&T MS 1 SICAV A.S.
       
      By: /s/ Michal Kusák
     
        Name: Michal Kusák
        Title: Director

     

      AMISTA INVESTIČNÍ SPOLEČNOST, A.S.
       
      By: /s/ Ondřej Horák
     
        Name: Ondřej Horák
        Title: Chairman of the Board of Directors

     

      AMISTA INVESTIČNÍ SPOLEČNOST, A.S.
       
         
      By: /s/ Michal Kusák
     
        Name: Michal Kusák
        Title: Member of the Board of Directors

     

    CUSIP No. G9329Z100

     

    Appendix A

     

    TRANSACTIONS IN THE COMMON SHARES EFFECTED BY THE REPORTING PERSON SINCE THE SECOND AMENDMENT

     

      Reporting Person Date of Transaction Shares Purchased (Sold) Price per Share ($)  
    J&T MS 1 December 19, 2022 340,000 $0.5184
    J&T MS 1 December 20, 2022 145,000 $0.5082
    J&T MS 1 December 21, 2022 44,407 $0.4999
    J&T MS 1 December 22, 2022 205,593 $0.4985

     

    Get the next $VNTR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VNTR

    DatePrice TargetRatingAnalyst
    10/6/2022$2.04 → $0.65Neutral → Sell
    UBS
    9/19/2022$2.00 → $0.60Market Perform → Underperform
    BMO Capital Markets
    3/22/2022$2.50 → $2.00Neutral → Underperform
    BofA Securities
    2/23/2022$4.50 → $3.00Buy
    Deutsche Bank
    1/4/2022$3.50 → $2.95Neutral
    UBS
    8/16/2021$5.50 → $4.50Buy
    Deutsche Bank
    8/5/2021$3.50Buy → Neutral
    B of A Securities
    More analyst ratings

    $VNTR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Venator Reaches Comprehensive Agreement to Enter Prepackaged Chapter 11 to Significantly Reduce Debt and Promptly Emerge Positioned for Long-Term Growth

      WYNYARD, UK, May 15, 2023 /PRNewswire/ -- Venator Materials PLC ("Venator" or the "Company") (NYSE:VNTR), a global manufacturer and marketer of chemical products, announces that it has reached an agreement with the overwhelming majority of its lenders and noteholders on the terms of a comprehensive recapitalization plan. The agreement will equitize nearly all of the Company's funded debt, strengthen its balance sheet and facilitate an infusion of new capital, which will position the Company for future growth and success.   The recapitalization will be implemented through a prepackaged Chapter 11 process in the United States and will be financed by a debtor-in-possession ("DIP") financing fac

      5/15/23 6:00:00 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Completes Divestiture of Iron Oxide Business

      WYNYARD, UK, April 3, 2023 /PRNewswire/ -- Venator Materials PLC ("Venator") (NYSE:VNTR) announced today that it has completed the sale of its Iron Oxide business to Cathay Industries. The enterprise value of the transaction was $140 million and Venator expects to receive cash proceeds of approximately $130 million net of working capital adjustments, taxes, fees and other closing cash adjustments. Venator expects an approximate $50 million reduction of its ABL facility resulting in a net liquidity improvement of approximately $80 million. About VenatorVenator is a global manufacturer and marketer of chemical products that comprise a broad range of pigments and additives that bring color and

      4/3/23 6:32:00 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Files Annual Report on Form 20-F

      WYNYARD, UK,  Feb. 23, 2023 /PRNewswire/ -- Venator Materials PLC ("Venator") (NYSE:VNTR) has filed its annual report on Form 20-F for the year ended December 31, 2022, with the U.S. Securities and Exchange Commission. The 2022 Form 20-F is available on Venator's website at https://www.venatorcorp.com/investor-relations and on the website of the U.S. Securities and Exchange Commission at www.sec.gov. Hard copies of the complete audited financial statements included in the 2022 Form 20-F are available to shareholders free of charge upon request. About VenatorVenator is a global manufacturer and marketer of chemical products that comprise a broad range of pigments and additives that bring colo

      2/23/23 4:15:00 PM ET
      $VNTR
      Major Chemicals
      Industrials

    $VNTR
    Leadership Updates

    Live Leadership Updates

    See more
    • Venator Announces Changes to Board of Directors

      WYNYARD, UK, Aug. 9, 2022 /PRNewswire/ -- Venator Materials PLC (NYSE:VNTR) ("Venator") today announced the resignation of Kathy Patrick from its Board of Directors and the appointment of Miguel Kohlmann to its Board of Directors, both effective August 9, 2022. Ms. Patrick has served as a director since the Company's IPO in 2017 and served on Venator's Audit Committee and Compensation Committee at the time of her resignation. She is resigning due to other professional commitments. Mr. Kohlmann is based in Europe and has substantial industry experience as a former CEO and via service on a number of boards, including the listed Danish building materials group H+H.  Mr. Kohlmann is an independe

      8/9/22 4:15:00 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Board Appoints New Director

      WYNYARD, UK, Feb. 11, 2021 /PRNewswire/ -- Venator Materials PLC (NYSE: VNTR) ("Venator") announced today that Vir Lakshman has been appointed to serve as a member of its Board of Directors. The appointment of Vir Lakshman was effective February 11, 2021. Mr. Lakshman worked for KPMG in Germany from 1999 to July 2019, where he was Head of Chemicals and Life Sciences in Germany and a Deal Advisory Partner. Prior to KPMG Mr. Lakshman held senior positions at GE Capital, including that of CFO at Budapest Bank in Hungary, and worked for Coopers and Lybrand (now PwC) in the UK and Germany. Mr. Lakshman, a UK Chartered Accountant, was appointed to serve as Chair of the Audit Committee. Simon Tu

      2/11/21 4:30:00 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Board Elects Three New Directors

      WYNYARD, UK, Jan. 4, 2021 /PRNewswire/ -- Venator Materials PLC (NYSE: VNTR) ("Venator") announced today that Barry B. Siadat, Aaron C. Davenport and Heike van de Kerkhof have been elected as new members to its Board of Directors. The appointment of Dr. Siadat was effective December 31, 2020. Prior to co-founding SK Capital Partners, Dr. Siadat worked for 37 years in the chemicals and materials industries as an inventor, operator and investor. Dr. Siadat has been the chairman of several specialty materials and chemicals companies. He currently serves as Chairman of the Board for Ascend Performance Materials, Aristech Acrylics, Archroma and SI Group. Additionally, he serves on the Board o

      1/4/21 6:59:00 AM ET
      $VNTR
      Major Chemicals
      Industrials

    $VNTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: van de Kerkhof Heike disposed of $47,152 worth of Ordinary Share (11,417 units at $4.13) and was granted 29,056 units of Ordinary Share to satisfy tax liability (Amendment)

      4/A - Venator Materials PLC (0001705682) (Issuer)

      4/28/21 3:34:44 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form 4: Huntsman Peter R was granted 29,056 units of Ordinary Share and disposed of $25,267 worth of Ordinary Share (6,118 units at $4.13), increasing direct ownership by 229% to 32,938 units to cover taxes (Amendment)

      4/A - Venator Materials PLC (0001705682) (Issuer)

      4/28/21 3:34:09 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form 4: Lakshman Vir was granted 29,056 units of Ordinary Share and disposed of $46,871 worth of Ordinary Share (11,349 units at $4.13) (tax liability) (Amendment)

      4/A - Venator Materials PLC (0001705682) (Issuer)

      4/28/21 3:35:28 PM ET
      $VNTR
      Major Chemicals
      Industrials

    $VNTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Venator Materials downgraded by UBS with a new price target

      UBS downgraded Venator Materials from Neutral to Sell and set a new price target of $0.65 from $2.05 previously

      10/6/22 7:35:46 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Materials downgraded by BMO Capital Markets with a new price target

      BMO Capital Markets downgraded Venator Materials from Market Perform to Underperform and set a new price target of $0.60 from $2.00 previously

      9/19/22 7:38:07 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Materials downgraded by BofA Securities with a new price target

      BofA Securities downgraded Venator Materials from Neutral to Underperform and set a new price target of $2.00 from $2.50 previously

      3/22/22 7:20:16 AM ET
      $VNTR
      Major Chemicals
      Industrials

    $VNTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Venator Materials PLC

      SC 13G - Venator Materials PLC (0001705682) (Subject)

      2/14/24 2:47:34 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form SC 13D filed by Venator Materials PLC

      SC 13D - Venator Materials PLC (0001705682) (Subject)

      12/4/23 5:09:58 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form SC 13D filed by Venator Materials PLC

      SC 13D - Venator Materials PLC (0001705682) (Subject)

      12/4/23 5:09:15 PM ET
      $VNTR
      Major Chemicals
      Industrials

    $VNTR
    Financials

    Live finance-specific insights

    See more
    • Venator Announces Fourth Quarter and Full-Year 2022 Results, Strategic Review Underway Against Challenging Macroeconomic Backdrop

      WYNYARD, UK, Feb. 21, 2023 /PRNewswire/ --  Fourth Quarter 2022 and Other Highlights The macro-economic environment deteriorated sharply in the second half of 2022 leading to significantly lower product demand and higher raw material and energy costs, with TiO2 sales volumes (44)% lower compared to the fourth quarter 2021 and (28)% lower compared to the prior periodNet loss attributable to Venator of $(228) million compared to net income of $14 million in the prior year periodAdjusted EBITDA of $(57) million compared to $40 million in the prior year periodNet cash used in operating activities was $(27) million and free cash flow was $(48) millionDiluted loss per share of $(2.11) and adjusted

      2/21/23 6:00:00 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator to Discuss Fourth Quarter and Full Year 2022 Results on February 21, 2023

      WYNYARD, UK, Feb. 9, 2023 /PRNewswire/ -- Venator Materials PLC (NYSE:VNTR) ("Venator") will hold a conference call to discuss its fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023, at 08:00 a.m. ET. Results will be released to the public before the market opens that day via PR Newswire. Call-in numbers for the conference call: U.S. participants 1-833-366-1118 International participants 1-412-902-6770 (No passcode required) In order to facilitate the registration process, you may use the following link to pre-register for the conference call. Callers who pre-register will be given a unique PIN and separate call-in number to gain immediate access to the call an

      2/9/23 6:00:00 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • Venator Strategic Review Update, Appointment of Advisors, Two New Independent Directors and Chairman, Engagement with Stakeholders

      Fourth Quarter 2022 Highlights Macro environment continues to be challenging due to significantly higher energy costs and lower product demandAdjusted EBITDA for the fourth quarter of 2022 estimated to be negative $(57)-(62) millionLiquidity position is estimated at approximately $275 million as of December 31, 2022Moelis & Company and Kirkland & Ellis appointed as respective financial and legal advisors, in addition to Alvarez & Marsal as the previously engaged operational advisor, to assist with strategic review and engagement with stakeholdersAppointment of two new independent directors, Stefan M. Selig and Jame Donath, who bring extensive and highly relevant experience to the BoardStefan

      1/20/23 6:45:00 AM ET
      $SAFE
      $SPG
      $VNTR
      Real Estate Investment Trusts
      Real Estate
      Major Chemicals
      Industrials

    $VNTR
    SEC Filings

    See more
    • SEC Form 15-12G filed by Venator Materials PLC

      15-12G - Venator Materials PLC (0001705682) (Filer)

      2/13/24 4:30:26 PM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form EFFECT filed by Venator Materials PLC

      EFFECT - Venator Materials PLC (0001705682) (Filer)

      2/12/24 12:15:06 AM ET
      $VNTR
      Major Chemicals
      Industrials
    • SEC Form S-8 POS filed by Venator Materials PLC

      S-8 POS - Venator Materials PLC (0001705682) (Filer)

      2/2/24 4:35:06 PM ET
      $VNTR
      Major Chemicals
      Industrials